Trials / Conditions / Invasive Meningococcal Disease
Invasive Meningococcal Disease
4 registered clinical trials studyying Invasive Meningococcal Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Acro NCT04184336 | Canadian Paediatric Society | — |
| Completed | Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older NCT01732627 | Sanofi Pasteur, a Sanofi Company | Phase 2 |
| Completed | Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults NCT01272180 | Novartis Vaccines | Phase 2 |
| Completed | Can we Reduce the Number of Vaccine Injections for Children? NCT01129518 | University of Oxford | Phase 4 |